Hints and tips:
Related Special Reports
...It has also worked on drug development for US pharma company Johnson & Johnson, Danish biotech group Genmab and British biotech Iksuda therapeutics....
...Japan’s sovereign development bank is investing in UK life sciences for the first time with funding for 4Bio Capital, a UK venture fund that backs advanced treatments such as cell and gene therapies....
...David Moore, vice-president for corporate development, added that the company would focus on acquisitions in diabetes and obesity, ideally in the early stage of development....
...[Enlarge] Further reading:— Alert: Alphaville LLC issues new research report on Duchy of Cornwall (FTAV)— Greenland: Alphaville put on its sellside hat for the deal of the century (FTAV)— Alphaville LLC...
...Lab monkey prices in China have plummeted as a post-pandemic slowdown in drug development ripples through the pharmaceutical sector in the world’s second-largest economy....
...It has pledged to double funding for dementia research to £160mn a year by 2025....
...Jodie Keane Senior Research Fellow ODI (Formerly Overseas Development Institute), London SE1, UK...
...Susan Galbraith, executive vice-president of oncology research and development at AstraZeneca, said there was an “opportunity to improve” on existing drugs in the area and that the Fusion acquisition would...
...Novo Nordisk purchased Dicerna Pharmaceuticals, a company focused in RNA-based therapeutics, for $3.3bn in 2021....
...This meant a significant proportion of cancer research was only possible because of public donations, she added....
...“They end up being clustered around genes that are altered in cancer in a variety of different ways, providing the first glimpse that these sequences may be key to tumour development,” he said....
...Timi Merriman-Johnson Sure. So there are individual stocks, which is how I got started. Although stock picking takes a lot of time and a lot of research and is......
...Johnson’s team have said he had acted as a “diplomatic back channel for the UK”, but the Foreign, Commonwealth and Development Office said he was “not acting on behalf of the UK government”....
...In contrast, pharmaceutical companies raised just $160mn for antibiotic research, a decline over the decade. Commercial activity and research in antibiotics have been in decline since the 1980s....
...In October, pharmaceuticals companies Eisai and Eli Lilly unveiled research showing the benefits of using new Alzheimer’s drugs very early in the development of the disease....
...A big obstacle to dealing with AMR is that decades of under-investment in research has led to a lack of promising new synthetic antibiotics....
...The reliance on animal testing brings further risks to the human subjects of clinical trials, and to the drug development process as a whole, Quantiphi argued....
...Colin Clarke, director of research at the Soufan Center, a New York-based intelligence and security consultancy, said Isis-K was “knocking on the door of Europe”, flagging the 2024 Paris Olympics as an event...
...The UK aims to lead the world in research, development and innovation. To do so, we must address the woeful lack of research funding and poor outcomes for the less survivable cancers....
...The UK spent about £66bn (around 2.9 per cent of gross domestic product, above the OECD average) on research and development in 2020, with business bankrolling about 60 per cent of it....
...A dearth of career scientists and public funding risks undermining efforts to use technological breakthroughs to tackle the biggest health threats, the head of a leading international research organisation...
...Spravato, a nasal spray based on a molecule from the psychedelic drug ketamine used to treat depression, already ranks as Johnson & Johnson’s fastest-growing product....
...High demand for weight-loss drugs has helped Novo Nordisk become Europe’s largest company by market capitalisation, while Eli Lilly overtook Johnson & Johnson as the world’s largest pharmaceutical company...
...Wegovy, alongside Eli Lilly’s tirzepatide-based drugs, which are both administered via weekly injections, are expected to generate $18.2bn in global sales this year, according to projections by research...
...not involved in the research....
International Edition